Journal
CLINICAL AND EXPERIMENTAL NEPHROLOGY
Volume 18, Issue 1, Pages 104-112Publisher
SPRINGER
DOI: 10.1007/s10157-013-0817-5
Keywords
Renal dysfunction; Glomerular disease; Tubular disease; Antiretroviral therapy; Tenofovir
Categories
Ask authors/readers for more resources
Renal disease is an increasingly recognized noninfectious comorbidity associated with human immunodeficiency virus (HIV) infection. Our retrospective, cross-sectional study evaluated prevalence of nephropathy among HIV-infected patients followed up in our outpatient clinic during the year 2011. Renal dysfunction and chronic kidney disease (CKD) were defined as estimated glomerular filtration rate (eGFR) < 90 ml/min per 1.73 m(2) and as renal damage or eGFR < 60 ml/min per 1.73 m(2) over a 3-month or greater period, respectively. We enrolled 894 HIV-infected patients with a mean age of 44.2 years and a mean current CD4 lymphocyte count of 508 cells/mm(3). The prevalence of renal dysfunction and CKD was 27.4 and 21.3 %, respectively. Older age, male gender, hypertension, diabetes, proteinuria, hypertriglyceridemia, lower nadir CD4 cell count, current use of tenofovir or tenofovir plus a ritonavir-boosted protease inhibitor were independently associated with renal dysfunction. Renal dysfunction is a frequent comorbidity among HIV-infected persons and requires a careful clinical and laboratory monitoring of renal function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available